Stereotactic MR-Adaptive Radiation Therapy for Early-stage Renal Cancer
for Primary Renal Cancer
1 location in New York
Sponsor: NYU Langone Health
Sex: All·Age: 18+
Code: NCT07767500·Recruiting·Listed Aug 17, 2026
Clinical Trials at NYU Langone Health
As of September 2026, 251 paid clinical trials are recruiting at NYU Langone Health, located at 550 1ST AVE, NEW YORK, NY 10016, phone (212) 263-1481 in New York, New York. Active studies at this site cover conditions such as Breast Cancer, Prostate Cancer and Multiple Myeloma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
Newly added in New York
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Young Onset Parkinson's Disease Subtypes and Pathogenic Mechanisms
for Young Onset Parkinson Disease
1 location in New York
Sponsor: NYU Langone Health
Sex: All·Age: 18+·Accepts healthy volunteers
Code: NCT07752355·Recruiting·Listed Aug 7, 2026
TRYPTYR as a Treatment for Patients With Dry Eye Disease (DED)
for Dry Eye Disease (DED)
1 location in New York
Sponsor: NYU Langone Health
Sex: All·Age: 18+
Code: NCT07732010·Phase 4·Recruiting·Listed Jul 28, 2026
Radiation After No Axillary Nodal Sampling
for Early-stage Breast Cancer
1 location in New York
Sponsor: NYU Langone Health
Sex: Female·Age: 40+
Code: NCT07723209·Recruiting·Listed Jul 23, 2026
255 clinical trials at NYU Langone Health
·Clear filters· Get a weekly email when new trials open in New York, NY.
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
for Hepatitis
Drug: Larsucosterol
Sites in New York, The Bronx +83 more locations
Sponsor: Bausch Health Americas, Inc.
Sex: All·Age: 18+
Code: NCT07428538·Phase 3·Recruiting·Listed Feb 2026
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
for Overweight
Drug: Eloralintide
Sites in New York +58 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07392190·Phase 3·Recruiting·Listed Feb 2026
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
for Clostridoides Difficile Associated Disease
Sites in New York, Brooklyn +138 more locations
Sponsor: Pfizer
Sex: All·Age: 65+·Accepts healthy volunteers
Code: NCT07282665·Phase 3·Recruiting·Listed Dec 2025
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
for Metabolic Dysfunction-Associated Steatotic Liver Disease
Sites in New York, Yonkers +140 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07165028·Phase 3·Recruiting·Listed Sep 2025
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
for Breast Neoplasms
Sites in New York, Babylon +46 more locations
Sponsor: Natera, Inc.
Sex: All·Age: 18+
Code: NCT07214532·Recruiting·Listed Oct 2025
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
for Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Drug: Coramitug
Sites in New York, Rosedale +59 more locations
Sponsor: Novo Nordisk A/S
Sex: All·Age: 18+
Code: NCT07207811·Phase 3·Recruiting·Listed Oct 2025
A Study of Dotinurad Versus Allopurinol in Participants With Gout
for Gout
Drug: Dotinurad
Sites in New York, Brooklyn +68 more locations
Sponsor: Crystalys Therapeutics
Sex: All·Age: 18 - 75
Code: NCT07089875·Phase 3·Recruiting·Listed Jul 2025
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
for Tophaceous Gout
Drug: Dotinurad
Sites in New York, Brooklyn +75 more locations
Sponsor: Crystalys Therapeutics
Sex: All·Age: 18 - 75
Code: NCT07089888·Phase 3·Recruiting·Listed Jul 2025
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
for Heart Failure
Drug: Empagliflozin
Sites in New York, The Bronx +92 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT06424288·Phase 3·Recruiting·Listed May 2024
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
for Primary Biliary Cholangitis
Sites in New York, Manhasset +50 more locations
Sponsor: Gilead Sciences
Sex: All·Age: 18+
Code: NCT06051617·Phase 3·Recruiting·Listed Sep 2023
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
for Glioma
Sites in New York, Rochester +44 more locations
Sponsor: Nuvation Bio Inc.
Sex: All·Age: 18+
Code: NCT05303519·Phase 3·Recruiting·Listed Mar 2022
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
for Non-Small Cell Lung Cancer
Sites in New York, Mineola +24 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT07100080·Phase 2, Phase 3·Recruiting·Listed Aug 2025
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
for Crohn's Disease
Drug: Ustekinumab
Sites in New York +40 more locations
Sponsor: Takeda
Sex: All·Age: 18 - 70
Code: NCT06045754·Phase 4·Recruiting·Listed Sep 2023
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
for Ulcerative Colitis
Drug: Tofacitinib
Sites in New York +36 more locations
Sponsor: Takeda
Sex: All·Age: 18 - 65
Code: NCT06095128·Phase 4·Recruiting·Listed Oct 2023
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
for Interstitial Lung Diseases
Drug: Nerandomilast
Sites in New York, Great Neck +30 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT06806592·Phase 3·Recruiting·Listed Feb 2025
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
for Solid Cancer
Sites in New York, Lake Success +23 more locations
Sponsor: Daiichi Sankyo
Sex: All·Age: 18+
Code: NCT06161025·Phase 2, Phase 3·Recruiting·Listed Dec 2023
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
for Advanced Solid Tumor
Sites in New York, Lake Success +22 more locations
Sponsor: Synthekine
Sex: All·Age: 18+
Code: NCT05098132·Phase 1, Phase 2·Recruiting·Listed Oct 2021
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
for Alzheimer's Disease
Drug: KarXT
Sites in New York, Syracuse +23 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 60 - 85
Code: NCT06976216·Phase 3·Recruiting·Listed May 2025
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
for Adjustment Disorder
Sites in New York, Buffalo +30 more locations
Sponsor: Reunion Neuroscience Inc
Sex: All·Age: 18 - 80
Code: NCT07002034·Phase 2·Recruiting·Listed Jun 2025
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
for Prostate Cancer
Drug: JANX007
Sites in New York, The Bronx +31 more locations
Sponsor: Janux Therapeutics
Sex: Male·Age: 18 - 100
Code: NCT05519449·Phase 1·Recruiting·Listed Aug 2022
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
for Cardiovascular Diseases
Sites in New York, The Bronx +45 more locations
Sponsor: BrioHealth Solutions, Inc.
Sex: All·Age: 18 - 100
Code: NCT06310031·Recruiting·Listed Mar 2024
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
for Lower Extremity Acute Limb Ischemia
Sites in New York +33 more locations
Sponsor: Penumbra Inc.
Sex: All·Age: 18+
Code: NCT06747117·Recruiting·Listed Dec 2024
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
for Colitis, Ulcerative
Sites in New York +26 more locations
Sponsor: Pfizer
Sex: All·Age: 18 - 64
Code: NCT06398626·Recruiting·Listed May 2024
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
for Low-grade NMIBC
Sites in New York, The Bronx +33 more locations
Sponsor: Tyra Biosciences, Inc
Sex: All·Age: 18+
Code: NCT06995677·Phase 2·Recruiting·Listed May 2025
A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC
for Adenocarcinoma, Pancreatic Ductal
Drug: Atezolizumab
Sites in New York, Uniondale +28 more locations
Sponsor: Genentech, Inc.
Sex: All·Age: 18+
Code: NCT05968326·Phase 2·Recruiting·Listed Aug 2023
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
for Liver Neoplasms
Sites in New York, Rochester +25 more locations
Sponsor: HistoSonics, Inc.
Sex: All·Age: 22+
Code: NCT06486454·Recruiting·Listed Jul 2024
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
for Symptomatic Heart Failure With Preserved Ejection Fraction (HFpEF)
Sites in New York +23 more locations
Sponsor: Cytokinetics
Sex: All·Age: 40 - 85
Code: NCT06793371·Phase 2·Recruiting·Listed Jan 2025
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
for Myositis
Sites in New York +37 more locations
Sponsor: Pfizer
Sex: All·Age: 18+
Code: NCT05895786·Phase 3·Recruiting·Listed Jun 2023
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
for Alpha1-Antitrypsin Deficiency
Sites in New York +32 more locations
Sponsor: Takeda
Sex: All·Age: 18 - 75
Code: NCT05677971·Phase 3·Recruiting·Listed Jan 2023
FORWARD CAD IDE Study
for Coronary Arterial Disease (CAD)
Sites in New York, Roslyn +26 more locations
Sponsor: Shockwave Medical, Inc.
Sex: All·Age: 18+
Code: NCT06662500·Recruiting·Listed Oct 2024
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
for In-Stent Restenosis
Sites in New York, The Bronx +26 more locations
Sponsor: Concept Medical Inc.
Sex: All·Age: 18 - 110
Code: NCT05908331·Recruiting·Listed Jun 2023
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
for Pancreatic Cancer
Drug: Atebimetinib
Sites in New York +36 more locations
Sponsor: Immuneering Corporation
Sex: All·Age: 18+
Code: NCT07562152·Phase 3·Recruiting·Listed May 2026
Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
for Atrial Fibrillation (AF)
Sites in New York, The Bronx +20 more locations
Sponsor: Medtronic Cardiac Ablation Solutions
Sex: All·Age: 18+
Code: NCT07298473·Recruiting·Listed Dec 2025
A Pivotal Study to Evaluate the Clinical Benefit, Performance and Safety of a Totally Implantable Cochlear Implant (TICI) System in Adults
for Hearing Loss, Bilateral Sensorineural
Sites in New York +10 more locations
Sponsor: Cochlear
Sex: All·Age: 18+
Code: NCT07287124·Recruiting·Listed Dec 2025
A Gaucher Disease Gene Therapy Trial With FLT201
for Gaucher Disease Type 1
Sites in New York +15 more locations
Sponsor: Spur Therapeutics
Sex: All·Age: 18+
Code: NCT07223944·Phase 3·Recruiting·Listed Nov 2025
A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy
for Symptomatic Genetic Dilated Cardiomyopathy
Sites in New York +27 more locations
Sponsor: Kardigan, Inc.
Sex: All·Age: 18+
Code: NCT07210723·Phase 2, Phase 3·Recruiting·Listed Oct 2025
IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)
for Relapsed/Refractory Primary Central Nervous System Lymphoma
Drug: Rituximab
Sites in New York +22 more locations
Sponsor: Ono Pharmaceutical Co., Ltd.
Sex: All·Age: 18+
Code: NCT07104032·Phase 3·Recruiting·Listed Aug 2025
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
for Recurrent or Metastatic Solid Tumors
Sites in New York, Westbury +15 more locations
Sponsor: Daiichi Sankyo
Sex: All·Age: 18+
Code: NCT06330064·Phase 1, Phase 2·Recruiting·Listed Mar 2024
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
for PIK3CA-Related Overgrowth Spectrum (PROS)
Sites in New York +21 more locations
Sponsor: Relay Therapeutics, Inc.
Sex: All·Age: 2+
Code: NCT06789913·Phase 2·Recruiting·Listed Jan 2025
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
for Carcinoma, Non-Small-Cell Lung
Sites in New York +17 more locations
Sponsor: Johnson & Johnson Enterprise Innovation Inc.
Sex: All·Age: 18+
Code: NCT06667908·Phase 2·Recruiting·Listed Oct 2024
Common conditions studied in New York
- Breast Cancer (92 active studies)
- Prostate Cancer (74 active studies)
- Multiple Myeloma (44 active studies)
- Colorectal Cancer (42 active studies)
- Ovarian Cancer (41 active studies)
- Endometrial Cancer (37 active studies)
Leading research sponsors in New York
- Memorial Sloan Kettering Cancer Center
- NYU Langone Health
- Columbia University
- Icahn School of Medicine at Mount Sinai
- Weill Medical College of Cornell University
Frequently asked questions
How many paid clinical trials are currently recruiting in New York?
There are approximately 3,375 recruiting clinical trials in New York, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in New York pay participants?
Most recruiting trials in New York compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in New York?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in New York?
The most common conditions under active study in New York include Breast Cancer (92), Prostate Cancer (74), Multiple Myeloma (44), Colorectal Cancer (42), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in New York?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in New York on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in New York?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in New York?
Recruiting research sites in New York include Memorial Sloan Kettering Cancer Center, NYU Langone Health, Icahn School of Medicine at Mount Sinai, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in New York right now?
The largest active categories in New York are Cancer & tumors (1,129), Neurology & pain (198), Cardiovascular (195). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of NYU Langone Health?
NYU Langone Health is located at 550 1ST AVE, NEW YORK, NY 10016. Use the Google Maps link in the intro above to get directions.
How do I contact NYU Langone Health?
You can reach NYU Langone Health by phone at (212) 263-1481. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.
Browse more clinical trials
Other cities in New York
The Bronx, NY(553)Rochester, NY(474)Buffalo, NY(415)Commack, NY(321)Harrison, NY(301)Uniondale, NY(226)Brooklyn, NY(205)Syracuse, NY(179)Stony Brook, NY(171)Albany, NY(164)Lake Success, NY(146)New Hyde Park, NY(120)Mineola, NY(116)Manhasset, NY(100)Valhalla, NY(97)Rockville Centre, NY(83)Staten Island, NY(77)East Syracuse, NY(57)Mount Kisco, NY(44)White Plains, NY(42)Amherst, NY(37)Bay Shore, NY(32)Flushing, NY(32)Westbury, NY(32)Great Neck, NY(31)Roslyn, NY(31)Webster, NY(29)Poughkeepsie, NY(26)Shirley, NY(26)Queens, NY(25)Long Island City, NY(24)Sleepy Hollow, NY(24)Ithaca, NY(22)Williamsville, NY(22)Glens Falls, NY(19)Garden City, NY(17)New Windsor, NY(17)West Islip, NY(17)Camillus, NY(16)Jamaica, NY(16)Cedarhurst, NY(15)Greenlawn, NY(15)Cooperstown, NY(14)Liverpool, NY(14)Manhattan, NY(14)Binghamton, NY(13)Hawthorne, NY(13)Laurelton, NY(13)Oswego, NY(13)Verona, NY(13)Clifton Park, NY(12)Port Jefferson Station, NY(12)Glen Oaks, NY(11)Rego Park, NY(11)East Hills, NY(10)Syosset, NY(10)East White Plains, NY(9)Huntington, NY(9)Oceanside, NY(9)Old Westbury, NY(9)